Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?

被引：18
|
作者：
Falk, Rodney H. [1 ]
机构：
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, Amyloidosis Program, 75 Francis St, Boston, MA 02115 USA
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷 / 12期
关键词：
CARDIAC AMYLOIDOSIS; DIAGNOSIS; VARIANT;
D O I：
10.1093/eurheartj/ehy697
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1009 / 1012
页数：4
相关论文
共 50 条
  • [1] Tafamidis for Transthyretin Amyloid Cardiomyopathy
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 773 - 773
  • [2] Tafamidis: A Review in Transthyretin Amyloid Cardiomyopathy
    Lamb, Yvette N.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (01) : 113 - 121
  • [3] Tafamidis for Transthyretin Amyloid Cardiomyopathy Reply
    Maurer, Mathew S.
    Sultan, Marla B.
    Rapezzi, Claudio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (02): : 196 - 197
  • [4] Tafamidis: A Review in Transthyretin Amyloid Cardiomyopathy
    Yvette N. Lamb
    [J]. American Journal of Cardiovascular Drugs, 2021, 21 : 113 - 121
  • [5] Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (05): : 505 - 505
  • [6] Tafamidis A Novel Treatment for Transthyretin Amyloid Cardiomyopathy
    Nawarskas, James J.
    Shephard, Emily A.
    [J]. CARDIOLOGY IN REVIEW, 2020, 28 (03) : 156 - 160
  • [7] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R. Rene
    Mann, C.
    Duca, F.
    Dachs, T-M
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Kastner, J.
    Eslam, R. Badr
    Bonderman, D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 252 - 253
  • [8] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Christopher, M.
    Duca, F.
    Dachs, T.
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Eslam, R. Badr
    Hengstenberg, C.
    Kastner, J.
    Bonderman, D.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S115 - S115
  • [9] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Duca, Franz
    Binder, Christina
    Capelle, Christophe
    Eslam, Roza Badr
    Aschauer, Stefan
    Mascherbauer, Julia
    Hengstenberg, Christian
    Bonderman, Diana
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S452 - S452
  • [10] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Duca, F.
    Binder, C.
    Capelle, C.
    Aschauer, S.
    Eslam, R. Badr
    Mascherbauer, J.
    Hengstenberg, C.
    Bonderman, D.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 494 - 494
12345